Posts By Alex
500Wire StoriesCeridian Reports Third Quarter 2023 Results
Dayforce® recurring revenue of $279.6 million, up 34.6% year-over-year, or 34.9% on a constant currency basis Total revenue of $377.5 million, up...
- 494Wire Stories
IperionX Receives US$12.7M U.S. Department of Defense Grant for Domestic Titanium Production
CHARLOTTE, N.C.–(BUSINESS WIRE)–$IPX #Virginia–IperionX Limited (IperionX) (NASDAQ: IPX, ASX: IPX) is pleased to announce that the U.S. Department of Defense (U.S. DoD)...
- 556Wire Stories
Gilat Awarded Approximately $20 Million in Contract Renewal and Extension from Tier-1 MNO in the USA
Gilat continues to support this long-term Tier-1 customer with a multi-year end-to-end managed services contract for satellite-based cellular backhaul and emergency response...
- 424Wire Stories
Global Copper Tubes Industry Report 2023-2028: Breakdown and Analysis of Straight Length, Coils, Pancakes or Flattened Tubes, U-Bends & Drawn Tubes – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Copper Tubes Market by Type (Straight Length, Coils, Pancakes or Flattened Tubes, U-Bends & Drawn Tubes), Thickness (Standard Gauge,...
- 503Wire Stories
Radware Reports Third Quarter 2023 Financial Results
Third Quarter 2023 Financial Results and Highlights Revenue of $61.6 million, down 13% year–over–year Cloud ARR of $62.5 million, up 25% year-over-year...
- 453Wire Stories
Heartseed Succeeds in Stable Production of High Purity Cardiomyocytes Using iPS Cells from I Peace, A Major Step Forward in Advancing Autologous Cardiac Regenerative Medicine
TOKYO & PALO ALTO, Calif.–(BUSINESS WIRE)–#Heartseed–Heartseed Inc. (“Heartseed”), a Tokyo-based biotechnology company developing iPSC-derived cardiomyocytes for heart failure and I Peace Inc....
- 438Wire Stories
Janus Henderson Group plc Reports Third Quarter 2023 Results
Solid investment performance, with 65%, 58%, 67%, and 72% of assets under management (“AUMâ€) outperforming relevant benchmarks on a one-, three-, five-,...
- 482Wire Stories
Start of Sales of Stainless Steel Materials for Injection Needles to Europe and China Compliant with the European Medical Device Regulations Cobalt Composition Regulations
NIPPON KINZOKU’s Original Steel Grade “NK-304LCO†TOKYO–(BUSINESS WIRE)–NIPPON KINZOKU CO., LTD. (TOKYO: 5491) (Headquarters: Minato-ku, Tokyo) commercialized “NK-304LCO†stainless steel for injection...
- 470Wire Stories
Sea Limited to Report Third Quarter 2023 Results
SINGAPORE–(BUSINESS WIRE)–Sea Limited (NYSE: SE) (“Sea†or the “Companyâ€) plans to announce its third quarter 2023 results before the U.S. market opens...
- 467Wire Stories
Kyocera Announces Consolidated Financial Results for Six Months Ended September 30, 2023
KYOTO, Japan–(BUSINESS WIRE)–Kyocera Corporation (TOKYO:6971) today announced its consolidated financial results for the first half of fiscal year 2024, covering the six...
